Stay updated on Durvalumab + Tremelumab in LS-SCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    New revision entry v3.6.6 is added to the study record history, and the previous revision v3.6.5 is removed. This updates the page’s version history to reflect the latest release.
    Difference
    0.1%
    Check dated 2026-08-29T20:22:57.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 was added to the study record history and the previous revision v3.6.4 was removed, updating the visible version history of the page.
    Difference
    0.1%
    Check dated 2026-08-08T22:41:02.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    A new release version (v3.6.4) was added to the page’s history. The previous version (v3.6.3) was removed, signaling a minor platform update reflected in the record history.
    Difference
    0.1%
    Check dated 2026-07-25T12:59:05.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The history now shows a new system revision labeled v3.6.3, replacing the previous v3.6.2, indicating a platform update rather than modifications to the study record.
    Difference
    0.1%
    Check dated 2026-07-03T23:18:20.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry (v3.6.2) superseding the previous (v3.6.0). This indicates an update to the page history on ClinicalTrials.gov rather than a change to the study data.
    Difference
    0.1%
    Check dated 2026-06-26T23:35:06.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    The recruitment notice now states that no participants are being sought, signaling that enrollment for the study has ended. A new revision tag (v3.6.0) was added to the record to capture this update in the study history.
    Difference
    0.2%
    Check dated 2026-06-12T17:18:37.000Z thumbnail image

Stay in the know with updates to Durvalumab + Tremelumab in LS-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.